Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan
Abstract
Our results present the current clinical preferences of anti-VEGF treatment for DME in Japan. The best-corrected visual acuity and the retinal thickness are important indicators to institute this therapy. The majority of the ophthalmologists use anti-VEGF treatment as first-line therapy and prefer t …
Keywords
disease management
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
prognosis
Cross-Sectional Studies
follow-up studies
Receptors
practice patterns
pmid:30204303
pmc6400162
doi:10.1111/jdi.12929
masahiko sugimoto
hideyuki tsukitome
taiji sakamoto
angiogenesis inhibitors / administration & dosage*
clinical competence
diabetic retinopathy / drug therapy*
intravitreal injections
macular edema / drug therapy*
ophthalmologists / statistics & numerical data
physicians' / statistics & numerical data*
ranibizumab / administration & dosage*
vascular endothelial growth factor / administration & dosage*
recombinant fusion proteins / administration & dosage*
vascular endothelial growth factor a / antagonists & inhibitors*
Access
Citation
ID:
112650
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112650
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
